Followers | 222 |
Posts | 13853 |
Boards Moderated | 0 |
Alias Born | 08/12/2011 |
Tuesday, May 30, 2017 2:56:52 AM
Per 10-Q, the following table summarizes the stages of development for each of our current Product Prospects.
Target Indication Collaborator Status
Multiple Myeloma Sheba Entered into a research agreement for in vitro studies agreement for in vitro studies
Negotiating terms of a Academic research agreement for in vivo studies
Medical Center Completed one in vitro study
Proceeding with further pre-
clinical in vitro studies
(safety and toxicity,
pharmacokinetic, and
pharmacodynamic)
Expect to submit a clinical
trial protocol to the Israeli
Institutional Review Board and
receive its approval to commence
a clinical study.
Intend to commence a clinical
study in the third quarter of
2017
Drafted a clinical trial
protocol synopsis, which we
believe will assist us in
preparing an application for
orphan status designation
Psoriasis Sheba Academic Medical Center
Entered into a Research Collaboration and License Agreement but have not commenced any studies to date
Received an IRB approval for a Phase I, double blind, randomized, placebo controlled, multiple escalating dose study to determine the safety, tolerability and pharmacokinetic profile of medical grade cannabis in healthy volunteers. The study began in April 2017.
Psoriasis Emilia Cosmetics Ltd. Entered into a
nonbinding memorandum of
understanding for the
development, manufacture and
marketing of a cannabinoid-based
topical cream.
We finished the development of the topical cream in the first quarter of 2016.
Fibromyalgia Sheba Drafted a clinical trial
protocol synopsis.
New delivery system - cannabis soluble tablet
G.C. Group Ltd. Completed a proof of concept (the R=Research phase) of the desired end product (the soluble tablet) to test the fabric, durability, solidification and other features of the cannabis soluble tablet.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM